Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Watercress Company is a leading international producer of watercress, with primary operations in the United Kingdom and Spain. The company distinguishes itself in the life sciences sector by actively funding and participating in clinical research to validate the health-promoting properties of its products. Its research focus primarily centers on the bioactive compound phenethyl isothiocyanate (PEITC) and its role in inhibiting cancer cell growth and reducing oxidative stress. Through collaborations with major research universities, the company has supported trials investigating the effects of watercress on breast cancer signaling and DNA repair. This evidence-based approach allows the company to position its products within the functional food and nutraceutical markets. The Watercress Company serves as a key industry partner for academic studies exploring the intersection of diet and chronic disease prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Watercress Company.